Treace Medical Concepts, Inc. Capital Expenditures
Treace Medical Concepts, Inc. (TMCI) reported Capital Expenditures of $5.26 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-07
- Treace Medical Concepts, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $2.20M, a 53.83% decline year-over-year.
- Treace Medical Concepts, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $3.06M, a 13.58% decline year-over-year.
- Treace Medical Concepts, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $2.40M, a 21.99% decline year-over-year.
- Treace Medical Concepts, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $2.81M, a 1.89% decline year-over-year.
- Treace Medical Concepts, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $13.52M, a 16.60% increase from fiscal 2024.
- Treace Medical Concepts, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $11.59M, a 1.18% increase from fiscal 2023.
- Treace Medical Concepts, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $11.46M, a 22.78% decline from fiscal 2022.
- Treace Medical Concepts, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $14.84M, a 448.54% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $5.26M 10-Q · filed 2026-08-07 | $7.66M derived: sum of 3 quarters · filed 2026-08-07 | $10.47M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $3.06M 10-Q · filed 2026-05-08 | $5.46M derived: sum of 2 quarters · filed 2026-05-08 | $8.27M derived: sum of 3 quarters · filed 2026-05-08 | $13.04M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $5.21M derived: sum of 2 quarters · filed 2026-02-27 | $9.97M derived: sum of 3 quarters · filed 2026-08-07 | $13.52M 10-K · filed 2026-02-27 |
| 2025-09-30 | $2.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $7.58M derived: sum of 2 quarters · filed 2026-08-07 | $11.12M 10-Q · filed 2025-11-06 | $14.19M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $4.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $8.31M 10-Q · filed 2026-08-07 | $11.38M derived: sum of 3 quarters · filed 2026-08-07 | $14.25M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $3.54M 10-Q · filed 2026-05-08 | $6.62M derived: sum of 2 quarters · filed 2026-05-08 | $9.48M derived: sum of 3 quarters · filed 2026-05-08 | $11.21M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $3.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $5.94M derived: sum of 2 quarters · filed 2026-02-27 | $7.67M derived: sum of 3 quarters · filed 2026-02-27 | $11.59M 10-K · filed 2026-02-27 |
| 2024-09-30 | $2.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $4.59M derived: sum of 2 quarters · filed 2025-11-06 | $8.52M 10-Q · filed 2025-11-06 | $10.77M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $1.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $5.66M 10-Q · filed 2025-08-07 | $7.90M derived: sum of 3 quarters · filed 2026-02-27 | $11.40M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $3.93M 10-Q · filed 2025-05-08 | $6.17M derived: sum of 2 quarters · filed 2026-02-27 | $9.68M derived: sum of 3 quarters · filed 2026-02-27 | $13.91M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $5.75M derived: sum of 2 quarters · filed 2026-02-27 | $9.98M derived: sum of 3 quarters · filed 2026-02-27 | $11.46M 10-K · filed 2026-02-27 |
| 2023-09-30 | $3.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $7.73M derived: sum of 2 quarters · filed 2024-11-05 | $9.21M 10-Q · filed 2024-11-05 | $11.54M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $4.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $5.71M 10-Q · filed 2024-08-06 | $8.04M derived: sum of 3 quarters · filed 2025-02-27 | $13.90M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $1.48M 10-Q · filed 2024-05-07 | $3.81M derived: sum of 2 quarters · filed 2025-02-27 | $9.67M derived: sum of 3 quarters · filed 2025-02-27 | $14.84M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $2.33M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $8.19M derived: sum of 2 quarters · filed 2025-02-27 | $13.36M derived: sum of 3 quarters · filed 2025-02-27 | $14.84M 10-K · filed 2025-02-27 |
| 2022-09-30 | $5.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $11.03M derived: sum of 2 quarters · filed 2023-11-09 | $12.51M 10-Q · filed 2023-11-09 | $13.41M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $5.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $6.65M 10-Q · filed 2023-08-09 | $7.55M derived: sum of 3 quarters · filed 2024-02-27 | $8.49M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $1.48M 10-Q · filed 2023-05-09 | $2.38M derived: sum of 2 quarters · filed 2024-02-27 | $3.32M derived: sum of 3 quarters · filed 2024-02-27 | $3.99M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.84M derived: sum of 2 quarters · filed 2024-02-27 | $2.51M derived: sum of 3 quarters · filed 2024-02-27 | $2.71M 10-K · filed 2024-02-27 |
| 2021-09-30 | $939.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.61M derived: sum of 2 quarters · filed 2022-11-09 | $1.80M 10-Q · filed 2022-11-09 | $1.89M derived: sum of 4 quarters · filed 2023-03-08 |
| 2021-06-30 | $670.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $866.00K 10-Q · filed 2022-08-10 | $954.00K derived: sum of 3 quarters · filed 2023-03-08 | $1.01M derived: sum of 4 quarters · filed 2023-03-08 |
| 2021-03-31 | $196.00K 10-Q · filed 2022-05-06 | $284.00K derived: sum of 2 quarters · filed 2023-03-08 | $342.00K derived: sum of 3 quarters · filed 2023-03-08 | $591.00K derived: sum of 4 quarters · filed 2023-03-08 |
| 2020-12-31 | $88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $146.00K derived: sum of 2 quarters · filed 2023-03-08 | $395.00K derived: sum of 3 quarters · filed 2023-03-08 | $1.07M 10-K · filed 2023-03-08 |
| 2020-09-30 | $58.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $307.00K derived: sum of 2 quarters · filed 2021-11-04 | $981.00K 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $249.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $923.00K 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $674.00K 10-Q · filed 2021-05-25 | |||
| 2019-12-31 | $1.21M 10-K · filed 2022-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |